These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 25772019

  • 1. Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.
    Tan TC, Bouras S, Sawaya H, Sebag IA, Cohen V, Picard MH, Passeri J, Kuter I, Scherrer-Crosbie M.
    J Am Soc Echocardiogr; 2015 May; 28(5):509-14. PubMed ID: 25772019
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW, Ali MT, Tan TC, Cheng KH, Salama L, Hua L, Zeng X, Halpern EF, Taghian A, MacDonald SM, Scherrer-Crosbie M.
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [Abstract] [Full Text] [Related]

  • 4. Subclinical Myocardial Impairment Occurred in Septal and Anterior LV Wall Segments After Anthracycline-Embedded Chemotherapy and did not Worsen During Adjuvant Trastuzumab Treatment in Breast Cancer Patients.
    Lange SA, Jung J, Jaeck A, Hitschold T, Ebner B.
    Cardiovasc Toxicol; 2016 Apr; 16(2):193-206. PubMed ID: 26022230
    [Abstract] [Full Text] [Related]

  • 5. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N, Tan TC, Ali M, Halpern EF, Wang L, Scherrer-Crosbie M.
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
    [Abstract] [Full Text] [Related]

  • 6. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW, Richards DA, Boyd A, Hui R, Harnett PR, Meikle SR, Byth K, Stuart K, Clarke JL, Thomas L.
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.
    Keramida K, Farmakis D, Bingcang J, Sulemane S, Sutherland S, Bingcang RA, Ramachandran K, Tzavara C, Charalampopoulos G, Filippiadis D, Kouris N, Nihoyannopoulos P.
    Eur J Heart Fail; 2019 Apr; 21(4):529-535. PubMed ID: 30811091
    [Abstract] [Full Text] [Related]

  • 8. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy.
    Stoodley PW, Richards DA, Hui R, Boyd A, Harnett PR, Meikle SR, Clarke J, Thomas L.
    Eur J Echocardiogr; 2011 Dec; 12(12):945-52. PubMed ID: 21965152
    [Abstract] [Full Text] [Related]

  • 9. Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients.
    Mele D, Malagutti P, Indelli M, Ferrari L, Casadei F, Da Ros L, Pollina A, Fiorencis A, Frassoldati A, Ferrari R.
    Ultrasound Med Biol; 2016 Jan; 42(1):125-32. PubMed ID: 26603736
    [Abstract] [Full Text] [Related]

  • 10. Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: results from a single-center retrospective study.
    Bergamini C, Torelli F, Ghiselli L, Rossi A, Trevisani L, Vinco G, Truong S, Benfari G, LA Russa F, Golia G, Molino A, Vassanelli C.
    Minerva Cardioangiol; 2017 Jun; 65(3):278-287. PubMed ID: 27886160
    [Abstract] [Full Text] [Related]

  • 11. Does Trastuzumab Cause Cardiotoxicity in the Treatment of Patients with Breast Cancer?
    Zhang X, Yang Y.
    J Am Soc Echocardiogr; 2015 Sep; 28(9):1129. PubMed ID: 26059949
    [No Abstract] [Full Text] [Related]

  • 12. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
    Gong IY, Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, Graham JJ, Chow CM, Thavendiranathan P, Dai D, Ng MY, Barfett JJ, Connelly KA, Yan AT.
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):653-662. PubMed ID: 30390170
    [Abstract] [Full Text] [Related]

  • 13. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC, Sandhu NP, Xia H, Cha SS, Pellikka PA, Ye Z, Herrmann J, Villarraga HR.
    BMC Cancer; 2018 Oct 25; 18(1):1037. PubMed ID: 30359235
    [Abstract] [Full Text] [Related]

  • 14. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.
    Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popović ZB, Marwick TH.
    J Am Coll Cardiol; 2013 Jan 08; 61(1):77-84. PubMed ID: 23199515
    [Abstract] [Full Text] [Related]

  • 15. Serial Measurements of Left Ventricular Systolic and Diastolic Function by Cardiac Magnetic Resonance Imaging in Patients with Early Stage Breast Cancer on Trastuzumab.
    Song L, Brezden-Masley C, Ramanan V, Ghugre N, Barfett JJ, Chan KKW, Haq R, Petrella T, Dhir V, Jimenez-Juan L, Chacko BR, Kotha V, Connelly KA, Yan AT.
    Am J Cardiol; 2019 Apr 01; 123(7):1173-1179. PubMed ID: 30683420
    [Abstract] [Full Text] [Related]

  • 16. Temporal Trends of Cardiac Chambers Function with Trastuzumab in Human Epidermal Growth Factor Receptor II-Positive Breast Cancer Patients.
    Moustafa S, Murphy K, Nelluri BK, Northfelt D, Shah P, Lee H, Wilansky S, Naqvi TZ, Meyer S, Mookadam F.
    Echocardiography; 2016 Mar 01; 33(3):406-15. PubMed ID: 26498324
    [Abstract] [Full Text] [Related]

  • 17. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
    Paraskevaidis IA, Makavos G, Tsirigotis P, Psarogiannakopoulos P, Parissis J, Gkirkas K, Pessach I, Ikonomidis I.
    J Am Soc Echocardiogr; 2017 Nov 01; 30(11):1091-1102. PubMed ID: 28864152
    [Abstract] [Full Text] [Related]

  • 18. Abnormal Myocardial Strain Indices in Children Receiving Anthracycline Chemotherapy.
    Pignatelli RH, Ghazi P, Reddy SC, Thompson P, Cui Q, Castro J, Okcu MF, Jefferies JL.
    Pediatr Cardiol; 2015 Dec 01; 36(8):1610-6. PubMed ID: 26049414
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
    Yu AF, Manrique C, Pun S, Liu JE, Mara E, Fleisher M, Patil S, Jones LW, Steingart RM, Hudis CA, Dang CT.
    Oncologist; 2016 Apr 01; 21(4):418-24. PubMed ID: 26984450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.